This is a "Reply Letter" addressing an ad hoc "Letter to the Editor", which was focused on our previously published IAEM article, entitled "The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: Implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies".
The SARS‑CoV‑2 receptor, ACE‑2, is expressed on many different cell types: implications for ACE‑inhibitor‑ and angiotensin II receptor blocker‑based cardiovascular therapies (Reply Letter).
Di Guardo GWriting – Review & Editing
;
2020-01-01
Abstract
This is a "Reply Letter" addressing an ad hoc "Letter to the Editor", which was focused on our previously published IAEM article, entitled "The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: Implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies".File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
